Skip to content
Indian Journal of Pharmacy Practice
An Open Access Peer reviewed Journal in Pharmaceutical Sciences
Connect with Us
Facebook
Twitter
Linkedin
VK
Youtube
Instagram
Primary Menu
Journal Home
Browse Issues
In Press
Current Issue
Past Issues
About
About APTI
About Journal
Editorial Board
Author Guidelines
Subscriptions
Contact Us
Search for:
Submit Article
Indian Journal of Pharmacy Practice, Vol 19, Issue 2, Apr-Jun, 2026
Recent Clinical Trials and Industry Updates on EGFR Inhibitors (2024-2025)
InJPharPract, Vol 19/Issue 2/2026
InJPharPract, Vol 19/Issue 2/2026
|
Recent Clinical Trials and Industry Updates on EGFR Inhibitors (2024-2025)
DOI:
10.5530/ijopp.20260568
Read More
Download PDF
Human Metapneumovirus in Focus: Emerging Insights into a Silent Respiratory Threat
InJPharPract, Vol 19/Issue 2/2026
InJPharPract, Vol 19/Issue 2/2026
|
Human Metapneumovirus in Focus: Emerging Insights into a Silent Respiratory Threat
DOI:
10.5530/ijopp.20260553
Read More
Download PDF
Clinical Pharmacology and Genomic Prescription Pathways: Toward a Paradigm Shift in Individualized Drug Therapy-A Review
InJPharPract, Vol 19/Issue 2/2026
InJPharPract, Vol 19/Issue 2/2026
|
Clinical Pharmacology and Genomic Prescription Pathways: Toward a Paradigm Shift in Individualized Drug Therapy-A Review
DOI:
10.5530/ijopp.20260563
Read More
Download PDF
Unveiling Tuberculosis through Retrospective Cross-Sectional Studies: A Prevalence Analysis
InJPharPract, Vol 19/Issue 2/2026
InJPharPract, Vol 19/Issue 2/2026
|
Unveiling Tuberculosis through Retrospective Cross-Sectional Studies: A Prevalence Analysis
DOI:
10.5530/ijopp.20260453
Read More
Download PDF
De-escalation of Antibiotics in Respiratory Tract Infection based upon Age, Gender and Culture Report
InJPharPract, Vol 19/Issue 2/2026
InJPharPract, Vol 19/Issue 2/2026
|
De-escalation of Antibiotics in Respiratory Tract Infection based upon Age, Gender and Culture Report
DOI:
10.5530/ijopp.20260529
Read More
Download PDF
Editor’s Pick
Recent Clinical Trials and Industry Updates on EGFR Inhibitors (2024-2025)
InJPharPract, Vol 19/Issue 2/2026
Recent Clinical Trials and Industry Updates on EGFR Inhibitors (2024-2025)
Human Metapneumovirus in Focus: Emerging Insights into a Silent Respiratory Threat
InJPharPract, Vol 19/Issue 2/2026
Human Metapneumovirus in Focus: Emerging Insights into a Silent Respiratory Threat
Clinical Pharmacology and Genomic Prescription Pathways: Toward a Paradigm Shift in Individualized Drug Therapy-A Review
InJPharPract, Vol 19/Issue 2/2026
Clinical Pharmacology and Genomic Prescription Pathways: Toward a Paradigm Shift in Individualized Drug Therapy-A Review
Unveiling Tuberculosis through Retrospective Cross-Sectional Studies: A Prevalence Analysis
InJPharPract, Vol 19/Issue 2/2026
Unveiling Tuberculosis through Retrospective Cross-Sectional Studies: A Prevalence Analysis